Loading
Created the ESMO Magnitude of Clinical Benefit Scale, the standard tool for grading how much a cancer drug really helps.
Nathan Cherny is Director of Cancer Pain and Palliative Medicine at Shaare Zedek Medical Center in Jerusalem and Chair of the ESMO-MCBS Working Group of the European Society for Medical Oncology (ESMO). His specialisms are palliative medicine, value assessment of cancer drugs and ethics. He created the ESMO Magnitude of Clinical Benefit Scale, which grades trial results by the size of the benefit they show and is used by health systems worldwide as the standard tool for judging how much a cancer drug really helps. His Annals of Oncology paper described this standardised, validated approach to stratifying clinical benefit. His publications are listed on PubMed.
Shares Standard of care, European Society for Medical Oncology (ESMO).
Shares Power trials to detect a benefit patients would value, not the smallest detectable one, Win-ratio endpoints that weigh survival, toxicity and quality of life together.
Shares Treat wasting like sepsis: a trigger, a bundle, an audit, Shaare Zedek Medical Center, European Society for Medical Oncology (ESMO).